An Evaluation of Hyperkalemia and Serum Creatinine Elevation Associated With Different Dosage Levels of Outpatient Trimethoprim-Sulfamethoxazole With and Without Concomitant Medications

Annals of Pharmacotherapy

Volumn 47, Issue 12, 2013, Pages 1618-1626

  Gentry, Chris A ^a   Nguyen, Ann T ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

hyperkalemia; renal insufficiency; trimethoprim sulfamethoxazole

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; COTRIMOXAZOLE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM; POTASSIUM ION; POTASSIUM SPARING DIURETIC AGENT; SPIRONOLACTONE;

ADULT; ARTICLE; CLINICAL EVALUATION; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG MEGADOSE; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; HYPERKALEMIA; INCIDENCE; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MIDDLE AGED; OUTPATIENT; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK;

HYPERKALEMIA; RENAL INSUFFICIENCY; TRIMETHOPRIM-SULFAMETHOXAZOLE;

ACUTE KIDNEY INJURY; ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-BACTERIAL AGENTS; CREATININE; FEMALE; HUMANS; HYPERKALEMIA; INCIDENCE; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; POTASSIUM; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 84891674339     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028013509973     Document Type: Article

References (27)

1. Wood JB,Smith DB,Baker EH,Brecher SM,Gupta K.Has the emergence of community-acquired methicillin-resistant Staphylococcus aureus increased trimethoprim-sulfamethoxazole use and resistance? A 10-year time series analysis.Antimicrob Agents Chemother. 2012;56:5655-5660.
2. Liu C,Bayer A,Cosgrove SEet al.Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.Clin Infect Dis. 2011;52:1-38.
3. Philadelphia, PA: AR Scientific Inc; 2012:.
4. Stein A,Bataille JF,Drancort Met al.Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole).Antimicrob Agents Chemother. 1998;42:3086-3091.
5. Alappan R,Buller GK,Perazella MA.Trimethoprim-sulfamethoxazole therapy in outpatients: is hyperkalemia a significant problem?.Am J Nephrol. 1999;19:389-394.
6. Ho JM,Juurlink DN.Considerations when prescribing trimethoprim-sulfamethoxazole.CMAJ. 2001;183:1851-1858.
7. Marinella MA.Trimethoprim-sulfamethoxazole associated with hyperkalemia.West J Med. 1997;167:356-358.
8. Trimethoprim-sulfamethoxazole monograph. Hudson, OH: Lexi-Drugs™, Lexi-Comp, Inc; 2011:.
9. Jick H.Adverse events to trimethoprim-sulfamethoxazole in hospitalized patients.Rev Infect Dis. 1982;4:426-428.
10. Roujeau JC,Kelly JP,Naldi Let al.Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.N Engl J Med. 1995;333:1600-1607.
11. Hughes W,Leoung G,Kramer Fet al.Comparison of atovaquone with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS.N Engl J Med. 1993;32821:1521-1527.
12. Wharton JM,Coleman DL,Wofsy CBet al.Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.Ann Intern Med. 1986;105:37-44.
13. Sattler FR,Frame P,Davis Ret al.Trimetrexate with leucovorin versus trimethoprim-sulfamethoxazole for moderate to severe episodes of Pneumocystis carinii pneumonia in patients with AIDS: a prospective, controlled multicenter investigation of the AIDS clinical trials group protocol 029/031.J Infect Dis. 1994;170:165-172.
14. Mori H,Kuroda Y,Imamura Set al.Hyponatremia and/or hyperkalemia in patients treated with the standard dose of trimethoprim-sulfamethoxazole.Intern Med. 2003;42:665-669.
15. Greenberg S,Reiser IW,Chou S,Porush JG.Trimethoprim-sulfamethoxazole induces reversible hyperkalemia.Ann Intern Med. 1993;119:291-295.
16. Noto H,Kaneko Y,Takano T,Kurokawa K.Severe hyponatremia and hyperkalemia induced by trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia.Intern Med. 1995;34:96-99.
17. Masters PA,O'Bryan TA,Zurlo J,Miller DQ,Joshi N.Trimethoprim-sulfamethoxazole revisited.Arch Intern Med. 2003;163:402-410.
18. PapaioannidesDBouropoulosCKorantzopoulosP. Co-trimoxazole induced acute thrombocytopenic purpura. Emerg Med J. 2003;20:e3http://www.emjonline.com/cgi/content/full/20/3/e3. Accessed October 8, 2013.
19. Fraser TN,Avellaneda AA,Graviss EA,Musher DM.Acute kidney injury associated with trimethoprim/sulfamethoxazole.J Antimicrob Chemother. 2012;67:1271-1277.
20. Nguyen AT,Gentry CA,Furrh RZ.A comparison of adverse drug reactions between high and standard-dose trimethoprim-sulfamethoxazole in the ambulatory setting.Curr Drug Saf. 2013;8:114-119.
21. Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health. DMID adult toxicity tables. http://www.niaid.nih.gov/labsandresources/resources/dmidclinrsrch/pages/toxtables.aspx. Accessed August 28, 2011.
22. Naderer O,Nafziger AN,Bertino JS.Effects of moderate-dose versus high-dose trimethoprim on serum creatinine and creatinine clearance and adverse events.Antimicrob Agents Chemother. 1997;41:2466-2470.
23. Ellis MW,Lewis JS.Treatment approaches for community-acquired methicillin-resistant Staphylococcus aureus infections.Curr Opin Infect Dis. 2005;18:496-501.
24. Daum RS.Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.N Engl J Med. 2007;357:380-390.
25. Antoniou T,Gomes T,Juurlink DN,Loutfy MR,Glazier RH,Mamdani MM.Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study.Arch Intern Med. 2010;170:1045-1049.
26. Cadena J,Nair S,Henao-Martinez AF,Jorgensen JH,Patterson JE,Sreeramoju PV.Dose of trimethoprim-sulfamethoxazole to treat skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother. 2011;55:5430-5432.
27. Rajendran PM,Young D,Maurer Tet al.Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection.Antimicrob Agents Chemother. 2007;51:4044-4048.